Dynavax Technologies Corp (DVAX)
11.35
-0.08
(-0.70%)
USD |
NASDAQ |
Apr 18, 16:00
11.35
0.00 (0.00%)
After-Hours: 18:58
Dynavax Technologies Cash from Operations (TTM): 100.56M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.56M |
| September 30, 2023 | 121.74M |
| June 30, 2023 | 152.18M |
| March 31, 2023 | 140.78M |
| December 31, 2022 | 62.72M |
| September 30, 2022 | 148.26M |
| June 30, 2022 | 152.92M |
| March 31, 2022 | 247.05M |
| December 31, 2021 | 335.53M |
| September 30, 2021 | 199.29M |
| June 30, 2021 | 105.26M |
| March 31, 2021 | -27.35M |
| December 31, 2020 | -92.25M |
| September 30, 2020 | -99.52M |
| June 30, 2020 | -93.68M |
| March 31, 2020 | -108.22M |
| December 31, 2019 | -121.25M |
| September 30, 2019 | -131.87M |
| June 30, 2019 | -143.76M |
| March 31, 2019 | -141.33M |
| December 31, 2018 | -131.30M |
| September 30, 2018 | -115.42M |
| June 30, 2018 | -98.68M |
| March 31, 2018 | -82.14M |
| December 31, 2017 | -77.52M |
| Date | Value |
|---|---|
| September 30, 2017 | -86.05M |
| June 30, 2017 | -97.13M |
| March 31, 2017 | -105.17M |
| December 31, 2016 | -107.05M |
| September 30, 2016 | -102.62M |
| June 30, 2016 | -97.41M |
| March 31, 2016 | -95.55M |
| December 31, 2015 | -92.56M |
| September 30, 2015 | -87.58M |
| June 30, 2015 | -87.67M |
| March 31, 2015 | -86.70M |
| December 31, 2014 | -73.74M |
| September 30, 2014 | -68.71M |
| June 30, 2014 | -57.88M |
| March 31, 2014 | -50.96M |
| December 31, 2013 | -58.67M |
| September 30, 2013 | -54.42M |
| June 30, 2013 | -54.51M |
| March 31, 2013 | -54.51M |
| December 31, 2012 | -43.81M |
| September 30, 2012 | -41.50M |
| June 30, 2012 | -41.86M |
| March 31, 2012 | -35.80M |
| December 31, 2011 | -47.12M |
| September 30, 2011 | -59.71M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-143.76M
Minimum
Jun 2019
335.53M
Maximum
Dec 2021
49.91M
Average
100.56M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
| Supernus Pharmaceuticals Inc | 111.08M |
| Ligand Pharmaceuticals Inc | 49.58M |
| Pacira BioSciences Inc | 154.65M |
| Esperion Therapeutics Inc | -135.49M |
| PetIQ Inc | 61.89M |